Due Diligence

Data privacy is now an important component in due diligences and investment cases. Ensuring the compliance of data collection and processing by a biotech, medical device, or AI company is now a critical factor in avoiding regulatory setbacks. It is essential to understand the methods of health data collection, whether secondary use was planned for, and whether fundamental security measures have been put in place.

As privacy regulations continue to expand, the necessity to apprehend the requirements of those laws is paramount.

How can iliomad Health Data help you ?

iliomad Health Data collaborates with Life Sciences investment funds, offering comprehensive privacy reports on prospective life sciences companies. These reports provide a comprehensive view of the privacy lifecycle of health data, covering everything from the initial data collection to subsequent data reuse and hosting. By identifying potential risks associated with privacy issues, iliomad Health Data delivers essential insights that guide and inform investment decisions.

Responsibility assessment
Data transfer and data hosting
Data governance
Gap analysis
Contractual review
Risk analysis
domain explain illustration

Any questions ?

Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.